| pubmed-article:6109048 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6109048 | lifeskim:mentions | umls-concept:C0014644 | lld:lifeskim |
| pubmed-article:6109048 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
| pubmed-article:6109048 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:6109048 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:6109048 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:6109048 | pubmed:issue | 8210 | lld:pubmed |
| pubmed-article:6109048 | pubmed:dateCreated | 1981-3-17 | lld:pubmed |
| pubmed-article:6109048 | pubmed:abstractText | Peripheral-blood mononuclear cells from renal-allograft patients receiving cyclosporin A (CSA) were tested for their ability to produce T cells cytotoxic for EB-virus-infected B-cell targets in culture and compared with those from healthy seropositive subjects. Whereas in the control cultures the proliferating foci of EB-virus-transformed B cells regressed after 2 weeks, no such regression was seen in cultures from CSA-treated patients. These results indicate that patients receiving CSA cannot mount a cytotoxic response to EB-virus-infected B cells in vitro. It is suggested that suppression of memory-T-cell proliferation contributes to the high incidence of lymphomas in CSA-treated renal-allograft recipients. | lld:pubmed |
| pubmed-article:6109048 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6109048 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6109048 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6109048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6109048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6109048 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6109048 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:6109048 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:6109048 | pubmed:author | pubmed-author:JanossyGG | lld:pubmed |
| pubmed-article:6109048 | pubmed:author | pubmed-author:HoffbrandA... | lld:pubmed |
| pubmed-article:6109048 | pubmed:author | pubmed-author:StoneR GRG | lld:pubmed |
| pubmed-article:6109048 | pubmed:author | pubmed-author:EdwardsJ MJM | lld:pubmed |
| pubmed-article:6109048 | pubmed:author | pubmed-author:CrawfordD HDH | lld:pubmed |
| pubmed-article:6109048 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6109048 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:6109048 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:6109048 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6109048 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6109048 | pubmed:pagination | 10-2 | lld:pubmed |
| pubmed-article:6109048 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:meshHeading | pubmed-meshheading:6109048-... | lld:pubmed |
| pubmed-article:6109048 | pubmed:year | 1981 | lld:pubmed |
| pubmed-article:6109048 | pubmed:articleTitle | Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. | lld:pubmed |
| pubmed-article:6109048 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6109048 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6109048 | lld:pubmed |
